GeoVax Labs Inc reports results for the quarter ended September 30 - Earnings Summary

Geovax Labs

12/11/2024 23:16

* GeoVax Labs Inc  GOVX.OQ  reported a quarterly adjusted
loss
of 91 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-4.80.  The mean expectation of four analysts
for the quarter was for a loss of $1.48 per share. Wall Street
expected results to range from $-2.04 to -91 cents per share.
    * Revenue was $2.79 million​; analysts expected $918.75
thousand. 
    * GeoVax Labs Inc's reported EPS for the quarter was a loss
of 91
cents​.
    * The company reported a quarterly loss of $5.82 million.
    * GeoVax Labs Inc shares had risen by 30.3% this quarter and
lost 42.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for GeoVax Labs Inc
is 16.50 
This summary was machine generated from LSEG data November 12 at
11:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.48          -0.91          Beat
 Jun. 30 2024      -3.36          -1.99          Beat
 Mar. 31 2024      -5.56          -2.47          Beat
 Dec. 31 2023      -2.78          -13.60         Missed